Literature DB >> 20616705

Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years.

José Mesquita-Bastos1, Susana Bertoquini, Jorge Polónia.   

Abstract

AIM: We investigated the cardiovascular (CV) prognostic value of 24-h ambulatory blood pressure (ABP) and blood pressure (BP) during the six 4-h periods of the 24-h ABP length in a cohort of 1200 Portuguese hypertensive patients (aged 51±12 years) without earlier CV events.
METHOD: The presence of CV events were followed for 9.833 patient years and analyzed using a cox hazard model.
RESULTS: During the 15.2 (mean 8.2) years follow-up, there were 152 CV events (11% fatal) including 79 strokes and 52 coronary events. After adjustment for risk factors and office BP (OBP), a 1-standard deviation increment of 24-h, daytime and night-time systolic BP (SBP) significantly predicted any CV event with hazard ratios (HR) 1.41, 1.33 and 1.57, respectively, and stroke with HR 1.67, 1.58, 1.67, respectively (all P<0.01), but not coronary events. Prognostic significance of these SBP values and of night-time ABP persisted after adjustment for diastolic BP and daytime ABP, respectively, whereas the opposite did not occur. SBP night-time fall (%) inversely predicted total CV events after adjustment for diastolic BP night-time fall. Among all six 4-h periods of 24-h, increment of SBP during the first 4 h of night-time was the most powerful predictor of any CV event (HR 1.64) and stroke (HR 2.02) (both P<0.01) even after adjustment for daytime and 24-h BP.
CONCLUSION: In predicting CV events and stroke, ABP is superior to office BP, ABP systolic is superior to ABP diastolic, and night-time BP is superior to daytime BP particularly during the first 4 h of sleep.

Entities:  

Mesh:

Year:  2010        PMID: 20616705     DOI: 10.1097/MBP.0b013e32833c8b08

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  8 in total

Review 1.  Implementing ABPM into Clinical Practice.

Authors:  Alan L Hinderliter; Raven A Voora; Anthony J Viera
Journal:  Curr Hypertens Rep       Date:  2018-02-05       Impact factor: 5.369

Review 2.  The evolution and refinement of traditional risk factors for cardiovascular disease.

Authors:  Emil M deGoma; Joshua W Knowles; Fabio Angeli; Matthew J Budoff; Daniel J Rader
Journal:  Cardiol Rev       Date:  2012 May-Jun       Impact factor: 2.644

3.  Reproducibility of blood pressure dipping: relation to day-to-day variability in sleep quality.

Authors:  Alan L Hinderliter; Faye S Routledge; James A Blumenthal; Gary Koch; Michael A Hussey; William K Wohlgemuth; Andrew Sherwood
Journal:  J Am Soc Hypertens       Date:  2013-07-12

4.  Exercise training in the management of patients with resistant hypertension.

Authors:  Fernando Ribeiro; Rui Costa; José Mesquita-Bastos
Journal:  World J Cardiol       Date:  2015-02-26

Review 5.  Ambulatory blood pressure monitoring in the prediction and prevention of coronary heart disease.

Authors:  Yuan-Yuan Kang; Yan Li; Ji-Guang Wang
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group.

Authors:  Jinho Shin; Sung Ha Park; Ju Han Kim; Sang Hyun Ihm; Kwang-il Kim; Woo Shik Kim; Wook Bum Pyun; Yu-Mi Kim; Sung-il Choi; Soon Kil Kim
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

7.  Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data.

Authors:  Sung Il Choi; Soon Kil Kim; Sungha Park; Ju Han Kim; Sang Hyun Ihm; Gwang-Il Kim; Woo Shik Kim; Wook Bum Pyun; Yu-Mi Kim; Jinho Shin
Journal:  Clin Hypertens       Date:  2016-01-27

8.  Office, Central, and Ambulatory Blood Pressure for Predicting First Stroke in Older Adults: A Community-Based Cohort Study.

Authors:  Kenji Matsumoto; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Joseph E Schwartz; Tatjana Rundek; Carlo Mannina; Kazato Ito; Ralph L Sacco; Marco R Di Tullio
Journal:  Hypertension       Date:  2021-07-12       Impact factor: 9.897

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.